Canada
· Delayed Price · Currency is CAD Eupraxia Pharmaceuticals Statistics
Total Valuation
TSX:EPRX has a market cap or net worth of CAD 191.08 million. The enterprise value is 195.01 million.
| Market Cap | 191.08M |
| Enterprise Value | 195.01M |
Important Dates
The last earnings date was Thursday, May 8, 2025.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:EPRX has 35.85 million shares outstanding. The number of shares has increased by 37.52% in one year.
| Current Share Class | 35.85M |
| Shares Outstanding | 35.85M |
| Shares Change (YoY) | +37.52% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 22.73% |
| Owned by Institutions (%) | 5.98% |
| Float | 24.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 4.92 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.09 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.50 |
Financial Position
The company has a current ratio of 13.00, with a Debt / Equity ratio of 0.00.
| Current Ratio | 13.00 |
| Quick Ratio | 12.59 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.00 |
| Interest Coverage | -43.00 |
Financial Efficiency
Return on equity (ROE) is -116.77% and return on invested capital (ROIC) is -62.63%.
| Return on Equity (ROE) | -116.77% |
| Return on Assets (ROA) | -52.06% |
| Return on Invested Capital (ROIC) | -62.63% |
| Return on Capital Employed (ROCE) | -101.48% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.16M |
| Employee Count | 33 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +37.63% in the last 52 weeks. The beta is 1.52, so TSX:EPRX's price volatility has been higher than the market average.
| Beta (5Y) | 1.52 |
| 52-Week Price Change | +37.63% |
| 50-Day Moving Average | 5.16 |
| 200-Day Moving Average | 4.37 |
| Relative Strength Index (RSI) | 58.77 |
| Average Volume (20 Days) | 48,241 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -39.43M |
| Pretax Income | -37.88M |
| Net Income | -38.30M |
| EBITDA | -39.26M |
| EBIT | -39.43M |
| Earnings Per Share (EPS) | -1.10 |
Balance Sheet
The company has 39.46 million in cash and 75,855 in debt, giving a net cash position of 39.39 million or 1.10 per share.
| Cash & Cash Equivalents | 39.46M |
| Total Debt | 75,855 |
| Net Cash | 39.39M |
| Net Cash Per Share | 1.10 |
| Equity (Book Value) | 38.86M |
| Book Value Per Share | -0.12 |
| Working Capital | 37.96M |
Cash Flow
In the last 12 months, operating cash flow was -42.92 million and capital expenditures -383,028, giving a free cash flow of -43.30 million.
| Operating Cash Flow | -42.92M |
| Capital Expenditures | -383,028 |
| Free Cash Flow | -43.30M |
| FCF Per Share | -1.21 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSX:EPRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -37.52% |
| Shareholder Yield | -37.52% |
| Earnings Yield | -20.05% |
| FCF Yield | -22.66% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |